Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Takeda R&D Chief Touts Pipeline Revolution, 70% of Research Now in Non-Small Molecules
Takeda Pharmaceutical’s R&D transformation has brought about a revolutionary change to its pipeline as it has raised its innovation bar and diversified modalities, with the number of non-small molecule candidates now accounting for 70% of its research, R&D President Andy…
To read the full story
Related Article
- No Need for Acquisitions over Next 5 Years, 12 NMEs to Counter Patent Cliff: Takeda CEO
November 26, 2019
- Takeda Eyes 12 NME Approvals over Next 5 Years
November 19, 2019
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





